DE69826019D1 - Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung - Google Patents

Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung

Info

Publication number
DE69826019D1
DE69826019D1 DE69826019T DE69826019T DE69826019D1 DE 69826019 D1 DE69826019 D1 DE 69826019D1 DE 69826019 T DE69826019 T DE 69826019T DE 69826019 T DE69826019 T DE 69826019T DE 69826019 D1 DE69826019 D1 DE 69826019D1
Authority
DE
Germany
Prior art keywords
vaccine composition
oral administration
solid dispersing
adjuvant
mucosal tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69826019T
Other languages
English (en)
Other versions
DE69826019T2 (de
Inventor
Harry Seager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of DE69826019D1 publication Critical patent/DE69826019D1/de
Application granted granted Critical
Publication of DE69826019T2 publication Critical patent/DE69826019T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
DE69826019T 1997-10-27 1998-10-27 Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung Expired - Lifetime DE69826019T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products
GB9722682 1997-10-27
PCT/GB1998/003209 WO1999021579A1 (en) 1997-10-27 1998-10-27 Solid dispersing vaccine composition for oral delivery

Publications (2)

Publication Number Publication Date
DE69826019D1 true DE69826019D1 (de) 2004-10-07
DE69826019T2 DE69826019T2 (de) 2005-09-15

Family

ID=10821162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69826019T Expired - Lifetime DE69826019T2 (de) 1997-10-27 1998-10-27 Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung

Country Status (10)

Country Link
EP (1) EP1024824B1 (de)
JP (1) JP2001521007A (de)
AT (1) ATE274919T1 (de)
AU (1) AU9635998A (de)
DE (1) DE69826019T2 (de)
DK (1) DK1024824T3 (de)
ES (1) ES2227885T3 (de)
GB (1) GB9722682D0 (de)
PT (1) PT1024824E (de)
WO (1) WO1999021579A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
LT1212045T (lt) 1999-08-24 2016-12-12 Abic Biological Laboratories Ltd. Vakcinos kompozicija ir jos panaudojimas
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
MXPA05009079A (es) 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CN100584385C (zh) * 2003-07-10 2010-01-27 协和发酵生化株式会社 片剂及其制备方法
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP2322194A2 (de) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
JP2009510136A (ja) 2005-10-04 2009-03-12 アルク−アベッロ エイ／エス 固体ワクチン製剤
EP2187926B1 (de) 2007-09-11 2012-01-25 Københavns Universitet Vorbeugung von Diabetes durch Verabreichung von Gliadin
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
JP2012533557A (ja) * 2009-07-17 2012-12-27 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ 舌上ワクチン及びアプリケーター
GB201009273D0 (en) 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
JP6061859B2 (ja) * 2010-10-08 2017-01-18 アール．ピー． シェーラー テクノロジーズ エルエルシー デンプンを使用する経口ワクチン速溶性剤型
EP2952200A1 (de) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen zur vorbeugenden Behandlung von Allergien
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
EP0688205A1 (de) * 1993-03-11 1995-12-27 Secretech, Inc. Mucoadhäsive polymere in der verabreichung von immunogenen an muköse oberflächen
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery

Also Published As

Publication number Publication date
PT1024824E (pt) 2004-11-30
GB9722682D0 (en) 1997-12-24
EP1024824B1 (de) 2004-09-01
DE69826019T2 (de) 2005-09-15
AU9635998A (en) 1999-05-17
ATE274919T1 (de) 2004-09-15
JP2001521007A (ja) 2001-11-06
DK1024824T3 (da) 2004-09-20
WO1999021579A1 (en) 1999-05-06
ES2227885T3 (es) 2005-04-01
EP1024824A1 (de) 2000-08-09

Similar Documents

Publication Publication Date Title
DE69826019D1 (de) Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
IL145982A0 (en) Vaccines
LU91326I2 (fr) Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé)
DE60012042D1 (de) Entepneumovirus und entsprechendes impfstoff
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
GB0025577D0 (en) Vaccine
DZ2462A1 (fr) Vaccin antigrippal.
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
ATE395916T1 (de) Orale methylphenidat-formulierungen mit kontrollierter/veränderter freisetzung
BR9910643A (pt) Processos e produtos para a indução de imunidadede mucosa
DK1259259T3 (da) Mucosal adjuvansformulering
DZ2283A1 (fr) Composition de vaccin.
EP1471936A4 (de) Hiv-vakzine und anwendungsverfahren
NO972219D0 (no) Immunogenpreparater
SI1140168T1 (en) Vaccination against cancer
DE69510858T2 (de) Mukosale Verabreichung von Pneumokokken-Antigenen
HUP0400495A3 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
CU23077A1 (es) Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas
MY127452A (en) Vaccines.
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней
UA23884A (uk) Спосіб підвищення імунітету у сільськогосподарськи х птиць при вакцинації її живими вірус-вакцинами

Legal Events

Date Code Title Description
8364 No opposition during term of opposition